Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma
靶向肿瘤血管抗原的树突状细胞疫苗与达沙替尼联合使用,可诱导免疫检查点抑制剂难治性晚期黑色素瘤患者产生治疗性免疫反应。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-003675
Storkus, Walter J; Maurer, Deena; Lin, Yan; Ding, Fei; Bose, Anamika; Lowe, Devin; Rose, Amy; DeMark, Melissa; Karapetyan, Lilit; Taylor, Jennifer L; Chelvanambi, Manoj; Fecek, Ronald J; Filderman, Jessica N; Looney, Timothy J; Miller, Lauren; Linch, Elizabeth; Lowman, Geoffrey M; Kalinski, Pawel; Butterfield, Lisa H; Tarhini, Ahmad; Tawbi, Hussein; Kirkwood, John M
黑色素瘤
肿瘤
肿瘤免疫
树突状细胞
细胞生物学
树突状细胞
免疫/内分泌